nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—ADORA2A—forebrain—attention deficit hyperactivity disorder	0.0336	0.0905	CbGeAlD
Theobromine—ADORA1—forebrain—attention deficit hyperactivity disorder	0.029	0.0781	CbGeAlD
Theobromine—ADORA2A—cardiovascular system—attention deficit hyperactivity disorder	0.0284	0.0765	CbGeAlD
Theobromine—ADORA1—cardiovascular system—attention deficit hyperactivity disorder	0.0245	0.0661	CbGeAlD
Theobromine—PDE4B—forebrain—attention deficit hyperactivity disorder	0.0214	0.0578	CbGeAlD
Theobromine—ADORA2A—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.0203	0.0323	CbGpPWpGaD
Theobromine—ADORA2A—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.02	0.0318	CbGpPWpGaD
Theobromine—ADORA1—midbrain—attention deficit hyperactivity disorder	0.0191	0.0516	CbGeAlD
Theobromine—ADORA2A—nervous system—attention deficit hyperactivity disorder	0.0182	0.0491	CbGeAlD
Theobromine—ADORA2A—central nervous system—attention deficit hyperactivity disorder	0.0176	0.0473	CbGeAlD
Theobromine—ADORA2A—cerebellum—attention deficit hyperactivity disorder	0.0172	0.0462	CbGeAlD
Theobromine—ADORA2A—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.0162	0.0258	CbGpPWpGaD
Theobromine—ADORA1—nervous system—attention deficit hyperactivity disorder	0.0157	0.0424	CbGeAlD
Theobromine—ADORA1—central nervous system—attention deficit hyperactivity disorder	0.0152	0.0408	CbGeAlD
Theobromine—ADORA1—cerebellum—attention deficit hyperactivity disorder	0.0148	0.0399	CbGeAlD
Theobromine—ADORA2A—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.0145	0.023	CbGpPWpGaD
Theobromine—PDE4B—midbrain—attention deficit hyperactivity disorder	0.0142	0.0382	CbGeAlD
Theobromine—ADORA2A—brain—attention deficit hyperactivity disorder	0.0139	0.0375	CbGeAlD
Theobromine—PDE4B—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0125	0.0199	CbGpPWpGaD
Theobromine—ADORA1—brain—attention deficit hyperactivity disorder	0.012	0.0324	CbGeAlD
Theobromine—PDE4B—nervous system—attention deficit hyperactivity disorder	0.0116	0.0314	CbGeAlD
Theobromine—ADORA1—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0115	0.0183	CbGpPWpGaD
Theobromine—PDE4B—central nervous system—attention deficit hyperactivity disorder	0.0112	0.0302	CbGeAlD
Theobromine—PDE4B—cerebellum—attention deficit hyperactivity disorder	0.011	0.0295	CbGeAlD
Theobromine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.01	0.027	CbGeAlD
Theobromine—ADORA2A—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00976	0.0155	CbGpPWpGaD
Theobromine—PDE4B—brain—attention deficit hyperactivity disorder	0.0089	0.024	CbGeAlD
Theobromine—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00867	0.0138	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00774	0.0123	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00718	0.0114	CbGpPWpGaD
Theobromine—PDE4B—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00704	0.0112	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00703	0.0112	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00698	0.0111	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00682	0.0108	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00662	0.0105	CbGpPWpGaD
Theobromine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00643	0.0173	CbGeAlD
Theobromine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00619	0.0167	CbGeAlD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00615	0.00978	CbGpPWpGaD
Theobromine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00605	0.0163	CbGeAlD
Theobromine—ADORA1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00605	0.00962	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00603	0.00958	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00554	0.00882	CbGpPWpGaD
Theobromine—ADORA2A—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0055	0.00874	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00543	0.00864	CbGpPWpGaD
Theobromine—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00541	0.00861	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00539	0.00858	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00525	0.00836	CbGpPWpGaD
Theobromine—ADORA2A—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00503	0.008	CbGpPWpGaD
Theobromine—CYP2E1—brain—attention deficit hyperactivity disorder	0.00492	0.0132	CbGeAlD
Theobromine—ADORA2A—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.0049	0.0078	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00488	0.00775	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00484	0.00769	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00484	0.00769	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00475	0.00755	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00469	0.00745	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00468	0.00745	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00467	0.00743	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00465	0.0074	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00459	0.0073	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00459	0.0073	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00455	0.00723	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00432	0.00687	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00426	0.00678	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00424	0.00674	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00418	0.00664	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00413	0.00658	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00406	0.00646	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00401	0.00638	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00396	0.0063	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00395	0.00628	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0039	0.0062	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00384	0.0061	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00377	0.006	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00376	0.00599	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00374	0.00595	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00374	0.00594	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00374	0.00594	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00372	0.00592	CbGpPWpGaD
Theobromine—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00367	0.00584	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00365	0.00581	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00362	0.00575	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00362	0.00575	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00358	0.0057	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00354	0.00563	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00354	0.00563	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00351	0.00558	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00347	0.00552	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00339	0.0054	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00329	0.00523	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00329	0.00523	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00327	0.0052	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00323	0.00514	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00323	0.00513	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00319	0.00508	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00318	0.00506	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00306	0.00486	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00305	0.00485	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00297	0.00473	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00296	0.00471	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00291	0.00463	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00288	0.00457	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00282	0.00448	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00278	0.00442	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00277	0.0044	CbGpPWpGaD
Theobromine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00277	0.0044	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00268	0.00426	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00265	0.00421	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00262	0.00417	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00262	0.00416	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00259	0.00412	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00258	0.00411	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00256	0.00408	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00254	0.00404	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0025	0.00398	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00249	0.00397	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00246	0.00392	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00246	0.00391	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00246	0.00391	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00243	0.00387	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00243	0.00386	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0024	0.00382	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00238	0.00378	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00236	0.00375	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00233	0.0037	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0023	0.00365	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00226	0.0036	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00215	0.00341	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00212	0.00337	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00209	0.00333	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00208	0.00331	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00204	0.00325	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.002	0.00318	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.002	0.00317	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00193	0.00307	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0019	0.00302	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00188	0.00298	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00188	0.00298	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00295	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00182	0.00289	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0018	0.00286	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00178	0.00282	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00175	0.00278	CbGpPWpGaD
Theobromine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00166	0.00265	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00165	0.00263	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00163	0.0026	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00163	0.0026	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00163	0.0026	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00161	0.00257	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00161	0.00256	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00159	0.00252	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00157	0.0025	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00157	0.0025	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00155	0.00247	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00152	0.00242	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00148	0.00235	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00147	0.00234	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00146	0.00232	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00146	0.00232	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00144	0.0023	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00143	0.00227	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00142	0.00226	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00141	0.00225	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00141	0.00224	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0014	0.00223	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0014	0.00222	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00139	0.00221	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.00221	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00139	0.00221	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00137	0.00219	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00137	0.00219	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00137	0.00218	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00136	0.00217	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00136	0.00216	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00135	0.00214	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00133	0.00211	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00131	0.00208	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00128	0.00204	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00128	0.00203	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00128	0.00203	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00127	0.00202	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00126	0.00201	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00201	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00126	0.002	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00125	0.00198	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00125	0.00198	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00123	0.00196	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00195	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00121	0.00193	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00121	0.00193	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00116	0.00185	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00115	0.00183	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00113	0.00179	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0011	0.00175	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00174	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.0011	0.00174	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.0011	0.00174	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00109	0.00174	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00107	0.00171	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00107	0.00171	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00106	0.00169	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00105	0.00168	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00102	0.00163	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000992	0.00158	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000988	0.00157	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000975	0.00155	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000964	0.00153	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000963	0.00153	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000953	0.00152	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000897	0.00143	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000896	0.00143	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00089	0.00142	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000885	0.00141	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000884	0.00141	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000878	0.0014	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000843	0.00134	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000833	0.00132	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000814	0.00129	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000804	0.00128	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000784	0.00125	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000774	0.00123	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000759	0.00121	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00075	0.00119	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000746	0.00119	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000745	0.00118	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000737	0.00117	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000737	0.00117	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000728	0.00116	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000692	0.0011	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000686	0.00109	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000678	0.00108	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000651	0.00103	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000628	0.000999	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000605	0.000963	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000605	0.000962	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000586	0.000932	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000576	0.000916	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000569	0.000905	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00053	0.000843	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000481	0.000764	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000475	0.000755	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000418	0.000665	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000418	0.000665	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000411	0.000654	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000382	0.000608	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000371	0.00059	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000364	0.000579	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000334	0.000531	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000318	0.000506	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000255	0.000405	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000253	0.000403	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000252	0.0004	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000251	0.0004	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000251	0.000399	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000251	0.000399	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000247	0.000393	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00023	0.000365	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000201	0.000319	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000197	0.000313	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000191	0.000304	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000152	0.000242	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000151	0.00024	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000147	0.000233	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000109	0.000173	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	6.53e-05	0.000104	CbGpPWpGaD
